Recruitment And Diversity
-
Endpoints, Procedures, And Deviations Are On The Rise — Why?
1/20/2026
SCRS Chief Site Success Officer Jimmy Bechtel, MBA, and Tufts CSDD Executive Director Ken Getz, MBA, discuss why they're on the rise explore ways to address, and even accept, them.
-
Confronting "Time Toxicity" In Global Oncology And Rare Disease Trials For Operational Excellence And Patient Retention
1/14/2026
Time is the only truly finite resource in a clinical trial. Consultant Leila Cupersmith discusses how sponsors can better design trials with a lower time burden to boost enrollment, retention, and overall operational excellence.
-
Researchers Want A Design Shake-Up In 2026
1/7/2026
When asked what clinical research professionals should leave behind in 2025, quite a few lamented the stale, even problematic, approach to clinical trial design. Here's what they want done differently in 2026.
-
The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
12/10/2025
Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
Designing Patient-Centric Recruitment Pathways With Real-Time Adherence Insights
12/8/2025
Learn how digital adherence solutions can enable real-time monitoring and site-level oversight to improve patient engagement and protocol compliance.
-
Patient Input Is A Must — Even Under Time And Money Constraints
12/4/2025
Stacie J. Bell, PhD, chief clinical research officer of Lupus Therapeutics, discusses the positive impacts patient advocacy groups can have on patient recruitment, patient retention, protocol design, and more.
-
Digital Biomarkers Are Reshaping Alzheimer's Patient Experience And Data
11/26/2025
Cognito CEO Christian Howell shares how EEG and digital biomarkers are reshaping recruitment, patient experience, and the quality of study data in Alzheimer’s research.
-
'ONE In A MILLION' Aims To Bridge The Equity Gap In Clinical Trials
11/20/2025
Tigerlily Foundation is launching its "ONE in a MILLION" national public-private partnership to engage one million people in high-risk communities with clinical research.
-
New Initiative Helps Researchers Enroll Healthy Volunteers In High Impact Trials
11/17/2025
1Day Sooner’s Director of Clinical Trials Circe MacDonald talks about their new Cooperative Patient Organization, the recruitment gaps it hopes to fill, and the importance of incorporating participant input.
-
Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs
11/13/2025
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.